Syndax Pharmaceuticals

$20.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.67 (-3.15%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SNDX and other stocks, options, and ETFs commission-free!

About SNDX

Syndax Pharmaceuticals, Inc. Common Stock, also called Syndax Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies.

CEO
Briggs W. Morrison
Employees
43
Headquarters
Waltham, Massachusetts
Founded
2005
Market Cap
1.00B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
715.92K
High Today
$21.76
Low Today
$20.34
Open Price
$21.34
Volume
565.33K
52 Week High
$27.85
52 Week Low
$9.83

SNDX Earnings

-$0.56
-$0.37
-$0.19
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

PBLA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure